XML 16 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities    
Net loss $ (31,285) $ (34,680)
Adjustments to reconcile net loss to net cash, cash equivalents, and restricted cash used in operating activities    
Depreciation and amortization 4,283 4,324
Accretion of lease right-of-use assets (88) (266)
Loss on extinguishment of liabilities   248
Share-based compensation expense 3,064 5,373
Change in fair value of warrant liability, net 280  
Provision for credit losses 109 453
Accrued interest, amortization of debt issuance costs and other 971 2,167
Inventory excess and obsolescence 21 20
Impairment loss on intangible assets 106 135
Changes in operating assets and liabilities:    
Accounts receivable (4,139) (810)
Other current assets 334 778
Other long-term assets (130) 49
Accounts payable and other accrued liabilities 885 (57)
Deferred revenue 2,014 273
Contingent consideration   (23,242)
Current and long-term operating lease liabilities (474) 682
Net cash, cash equivalents, and restricted cash used in operating activities (24,049) (44,553)
Cash flows from investing activities    
Purchase of property and equipment (173) (2,391)
Patent costs and intangible asset acquisition, net (126) (165)
Net cash, cash equivalents, and restricted cash used in investing activities (299) (2,556)
Cash flows from financing activities    
Proceeds from the issuance of common stock 5,000 55,625
Proceeds from issuance of common stock under employee stock purchase plan 497 624
Proceeds from exercise of stock options   19
Proceeds from term loan and notes payable 10,000  
Repayment of term loan and notes payable (16) (38)
Payment of debt issuance costs (30) (38)
Equity financing costs (188) (3,685)
Other (555) (276)
Net cash, cash equivalents, and restricted cash provided by financing activities 14,708 52,231
Net (decrease) increase in cash, cash equivalents, and restricted cash (9,640) 5,122
Cash, cash equivalents, and restricted cash ‑ beginning of period 26,332 26,371
Cash, cash equivalents, and restricted cash ‑ end of period 16,692 31,493
Supplemental cash flow information:    
Equity financing costs included in accounts payable and other accrued liabilities 194  
Operating lease right-of-use asset obtained in exchange for lease liabilities 732 281
Finance lease right-of-use assets obtained in exchange for lease liabilities 586 514
Cash paid for interest 4,686 4,443
Change in fair value of Perceptive Warrants 227  
Reclassification of Tranche C warrants to additional paid-in capital $ 280  
Purchases of property & equipment included in accounts payable and accrued liabilities   $ 526